Keywords: actelion, tracleer, gets, japanese, go-ahead, switzerland-based, received

Actelion's Tracleer gets Japanese go-ahead

Article | 07 March 2005

• Print This

Switzerland-based Actelion has received a favorable review of its pulmonary arterial hypertension therapy, Tracleer (bosentan) from the Japanese health authority.

Enjoying this article? To continue reading you need to login or subscribe.